Americhem, Inc, a globally recognized designer and manufacturer of custom color masterbatch, functional additives, engineered compounds, and performance technologies, has launched the EcoLube™ MD line of PFAS-free internally lubricated compounds specifically for medical devices and other healthcare applications.

“Our new PFAS-free EcoLube™ MD line showcases Americhem’s dedication to innovation, meeting their unique needs and helping them stay ahead in their respective markets.”

Health Technology Insights: Medical Aesthetic Devices Market Size: Straits Research

Building on the success of Americhem’s launch of EcoLube™ in 2024, EcoLube™ MD offers significant advantages for healthcare applications. As a sustainable, non-PFAS solution, EcoLube™ MD addresses the critical need for effective wear and friction reduction. It ensures compliance with current and future regulations, demonstrates environmental stewardship, and reduces environmental impact.

EcoLube™ MD pre-lubricated engineered compounds and alloys are designed to help manufacturers reduce the wear and friction of moving plastic parts, reduce noise during use, and decrease the coefficient of friction for plastic-on-plastic and plastic-on-metal applications, all without the use of PFAS components. End-use applications can include minimally invasive surgical devices, syringe pumps, prosthetics, surgical robots, and more.

Health Technology Insights: Asia Book of Records Honors Cipla for Record-Breaking Doctor engagement on COPD Awareness

Matt Miklos, Vice President/General Manager of Americhem’s engineered compounds division, noted that healthcare OEMs are increasingly concerned about sustainability and ensuring that new products meet current and future regulations.

“With regulations around the world potentially restricting or banning the use of PFAS and PTFE, healthcare OEMs are challenged with finding alternatives that can match their self-lubricating performance,” said Miklos. “Our new PFAS-free EcoLube™ MD line showcases Americhem’s dedication to innovation, meeting their unique needs and helping them stay ahead in their respective markets.”

Health Technology Insights: Change to the Roche Enlarged Corporate Executive Committee

To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com

Source – globenewswire